References
- Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997; 275: 964–967, [PUBMED], [INFOTRIEVE]
- Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J. M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999; 85: 221–228, [PUBMED], [INFOTRIEVE], [CSA]
- Chen C. H., Jiang W., Via D. P., Luo S., Li T. R., Lee Y. T., Henry P. D. Oxidized low‐density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 2000; 101: 171–177, [PUBMED], [INFOTRIEVE]
- Chen C. H., Jiang T., Yang J. H., Jiang W., Lu J., Marathe G. K., Pownall H. J., Ballantyne C. M., McIntyre T. M., Henry P. D., Yang C. Y. Low‐density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 2003; 107: 2102–2108, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Grant M. B., May W. S., Caballero S., Brown G. A., Guthrie S. M., Mames R. N., Byrne B. J., Vaught T., Spoerri P. E., Peck A. B., Scott E. W. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002; 8: 607–612, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hill J. M., Zalos G., Halcox J. P., Schenke W. H., Waclawiw M. A., Quyyumi A. A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003; 348: 593–600, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kalka C., Masuda H., Takahashi T., Kalka‐Moll W. M., Silver M., Kearney M., Li T., Isner J. M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 3422–3427, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kocher A. A., Schuster M. D., Szabolcs M. J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N. M., Itescu S. Neovascularization of ischemic myocardium by human bone‐marrow‐derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001; 7: 430–436, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mangin E., Jr., Kugiyama K., Nguy J., Kerns S., Henry P. D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium‐dependent relaxation of rabbit aorta. Circ. Res. 1993; 72: 161–166, [PUBMED], [INFOTRIEVE]
- Murayama T., Tepper O. M., Silver M., Ma H., Losordo D. W., Isner J. M., Asahara T., Kalka C. Determination of bone marrow‐derived endothelial progenitor cell significance in angiogenic growth factor‐induced neovascularization. Exp. Hematol. 2002; 30: 967–972, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., Onitsuka I., Matsui K., Imaizumi T. Transplanted cord blood‐derived endothelial progenitor cells augment postnatal neovascularization. J. Clin. Invest. 2000; 105: 1527–1536, [PUBMED], [INFOTRIEVE], [CSA]
- Peichev M., Naiyer A. J., Pereira D., Zhu Z., Lan W. J., Williams M., Oz M. C., Hicklin D. J., Witte L., Moore M. A., Rafii S. Expression of VEGFR‐2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952–958, [PUBMED], [INFOTRIEVE], [CSA]
- Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest 2000; 105: 17–19, [PUBMED], [INFOTRIEVE], [CSA]
- Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P. H., Verfaillie C. M. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 2002; 109: 337–346, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383–1389
- Steinberg D. Low density lipoprotein oxidation and its pathological significance. J. Biol. Chem. 1997; 272: 20963–20966, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Suzuki T., Nishida M., Futami S., Fukino K., Amaki T., Aizawa K., Chiba S., Hirai H., Maekawa K., Nagai R. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc. Res. 2003; 58: 487–492, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tepper O. M., Galiano D. R., Capla J. M., Kalka C., Gagne P. J., Jacobowitz G. R., Levine J. P., Gurtner G. C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781–2786, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A. M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cir. Res. 2001; 89: E1–E7
- Walter D. H., Rittig K., Bahlmann F. H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D. W., Asahara T., Isner J. M. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow‐derived endothelial progenitor cells. Circulation 2002; 105: 3017–3024, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 1991; 88: 1785–1792, [PUBMED], [INFOTRIEVE]